FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of Duchenne Muscular Dystrophy.
Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of Duchenne Muscular Dystrophy.
Zephyrx, a leading provider of end-to-end remote respiratory monitoring, has joined forces with EverythingALS on a new study to find a diagnosis, treatment, and cure for Amyotrophic Lateral Sclerosis.
The American Heart Association says some scientific evidence exists to challenge the belief that smoking marijuana is harmless and questions remain about its impact on brain health.
One in three survivors of COVID-19 suffered from neurologic or psychiatric disability six months after infection, a recent study of more than 200,000 post-COVID-19 patients showed.
Read MoreNeuromuscular/neurodegenerative disease involves an often-progressive weakness in the muscles that eventually may affect the pulmonary system and a person’s ability to breathe.
Read MoreIn two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barre syndrome after individuals were vaccinated against COVID-19.
Read MoreScientists at the University of York have made progress in the development of a nasal spray...
Read MoreOne in three survivors of COVID-19 suffer from neurologic or psychiatric disability six months after infection, a recent study of more than 200,000 post-COVID-19 patients showed.
Read MoreEarly findings of a small study suggest that children who had coronavirus-linked MIS-C also developed neurological symptoms.
Read MoreCT lung imaging and MRI brain scans have detected a visual correlation between COVID-19 disease...
Read MoreSleep plays a critical role in healing traumatic brain injury, according to a new study of military veterans published in the Journal of Neurotrauma.
Read MoreThe US FDA granted approval for Amondys 45 (casimersen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.
Read MoreNIH researchers connected frontotemporal dementia and amyotrophic lateral sclerosis (ALS) with the genetic mutation normally understood to cause Huntington’s disease.
Read MoreA new study on how the coronavirus affects the nervous system has revealed that the viral invader attacks its victim’s brain cells.
Read MoreThe FDA granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy in patients with a specific gene mutation.
Read More